Proteasome Inhibitors for Multiple Myeloma Market Outlook: Industry Overview and Forecast (2024 to 2031)

Market Overview and Report Coverage Proteasome Inhibitors are a class of drugs used in the treatment of Multiple Myeloma, a type of cancer that affects plasma cells in the bone marrow. These inhibitors work by blocking the action of proteasomes, whic...